Cargando…

Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy

Centronuclear myopathy (CNM) is a congenital neuromuscular disorder caused by pathogenic variation in genes associated with membrane trafficking and excitation–contraction coupling (ECC). Bi-allelic autosomal-recessive mutations in striated muscle enriched protein kinase (SPEG) account for a subset...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinosa, Karla G., Geissah, Salma, Groom, Linda, Volpatti, Jonathan, Scott, Ian C., Dirksen, Robert T., Zhao, Mo, Dowling, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118044/ https://www.ncbi.nlm.nih.gov/pubmed/35293586 http://dx.doi.org/10.1242/dmm.049437

Ejemplares similares

Novel SPEG variant cause centronuclear myopathy in China
por: Tang, Jia, et al.
Publicado: (2019)

A novel SPEG mutation causes non-compaction cardiomyopathy and neuropathy in a floppy infant with centronuclear myopathy
por: Wang, Haicui, et al.
Publicado: (2018)

Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene mutation: a case report and literature review
por: Zhang, Gang, et al.
Publicado: (2021)

Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008)

Pathogenic Mechanisms in Centronuclear Myopathies
por: Jungbluth, Heinz, et al.
Publicado: (2014)

Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline
por: Volpatti, Jonathan R, et al.
Publicado: (2020)

Autosomal Dominant Centronuclear Myopathy with Unique Clinical Presentations
por: Lee, Jee-Young, et al.
Publicado: (2007)

Suspected Congenital Centronuclear Myopathy in an Arabian‐cross Foal
por: Polle, F., et al.
Publicado: (2014)

Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands
por: Reumers, Stacha F. I., et al.
Publicado: (2021)

Phenotypic Spectrum of DNM2-Related Centronuclear Myopathy
por: Hayes, Leslie Hotchkiss, et al.
Publicado: (2022)

Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018)

A Possible Case of Centronuclear Myopathy: A Case Report
por: Castillo-Ferrán, Narjara, et al.
Publicado: (2023)

Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
por: Fajardo, Val A., et al.
Publicado: (2015)

DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy
por: Abath, Osorio, et al.
Publicado: (2015)

Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021)

Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model
por: Li, Qifei, et al.
Publicado: (2022)

Loss of Catalytically Inactive Lipid Phosphatase Myotubularin-related Protein 12 Impairs Myotubularin Stability and Promotes Centronuclear Myopathy in Zebrafish
por: Gupta, Vandana A., et al.
Publicado: (2013)

Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy
por: Park, Young-Eun, et al.
Publicado: (2014)

Phosphatase-Dead Myotubularin Ameliorates X-Linked Centronuclear Myopathy Phenotypes in Mice
por: Amoasii, Leonela, et al.
Publicado: (2012)

Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2
por: Hohendahl, Annika, et al.
Publicado: (2016)

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2017)

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin
por: Muñoz, Xènia Massana, et al.
Publicado: (2020)

MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy
por: Giraud, Quentin, et al.
Publicado: (2023)

Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy
por: Fraysse, Bodvaël, et al.
Publicado: (2016)

A rare case of centronuclear myopathy with DNM2 mutation: genotype–phenotype correlation
por: Aghbolaghi, Amir Ghorbani, et al.
Publicado: (2017)

Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy
por: Fouarge, Eve, et al.
Publicado: (2021)

A dog model for centronuclear myopathy carrying the most common DNM2 mutation
por: Böhm, Johann, et al.
Publicado: (2022)

Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants
por: Fujise, Kenshiro, et al.
Publicado: (2022)

Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy
por: Gómez-Oca, Raquel, et al.
Publicado: (2022)

DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy
por: de Carvalho Neves, Juliana, et al.
Publicado: (2023)

Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells
por: González-Jamett, Arlek M., et al.
Publicado: (2017)

Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy
por: Fujise, Kenshiro, et al.
Publicado: (2020)

Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation
por: Böhm, Johann, et al.
Publicado: (2010)

Aspergillus penicillioides Speg. Implicated in Keratomycosis
por: MACHOWICZ-MATEJKO, EULALIA, et al.
Publicado: (2018)

Exploring Obscurin and SPEG Kinase Biology
por: Fleming, Jennifer R., et al.
Publicado: (2021)

Mutations in BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and Oligomerization
por: Wu, Tingting, et al.
Publicado: (2014)

Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model
por: Fongy, Anaïs, et al.
Publicado: (2019)

UHPLC-MS Metabolome Fingerprinting: The Isolation of Main Compounds and Antioxidant Activity of the Andean Species Tetraglochin ameghinoi (Speg.) Speg.
por: Luna, Lorena, et al.
Publicado: (2018)

Tamoxifen therapy in a murine model of myotubular myopathy
por: Maani, Nika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vqns3i1m1m9krom6nefs0gu3q5